46. Carlier PR, Du DM, Han YF, Liu J, Perola E, Williams ID ong Hs, Pang Pang YP(2000) Angew Chem Int Ed 39: 1775-1777 47. Tang XC (1996)Acta Pharmacol Sin 17: 481-484 Chem6:1835-1850 48 Frobert Y, Creminon C, Cousin X, Remy MH, Chatel JM, Be Wong DM, Greenblatt HM, Dvir H, Carlier PR, Han Y, Pang S, Bon C, Grassi J(1997) Biochim Biophys Acta 1339: 253- YP, Silman I, Sussman JL (2003)J Am Chem Soc 125: 363- 49. Camps P, Cusack B, Mallender WD, El Achab R, Morral J 45. Xia Y(2002) The design and synthesis of Hup B derivatives Munoz-Torrero D, Rosenberry TL (2000)Mol Pharmacol based on the double active sites hypothesis of AchE. 57:409417 Dissertation, Shanghai, Shanghai Institute of Materia Medica Chinese Academy of Sciences42. Carlier PR, Han YF, Chow ESH, Li CPL, Wang H, Lieu TX, Wong HS, Pang YP (1999) Bioorg Med Chem 7:351–357 43. Mary A, Renko DZ, Guillou C, Thal C (1998) Bioorg Med Chem 6:1835–1850 44. Wong DM, Greenblatt HM, Dvir H, Carlier PR, Han Y, Pang YP, Silman I, Sussman JL (2003) J Am Chem Soc 125:363– 373 45. Xia Y (2002) The design and synthesis of Hup B derivatives based on the double active sites hypothesis of AchE. Dissertation, Shanghai, Shanghai Institute of Materia Medica Chinese Academy of Sciences 46. Carlier PR, Du DM, Han YF, Liu J, Perola E, Williams ID, Pang YP (2000) Angew Chem Int Ed 39:1775–1777 47. Tang XC (1996) Acta Pharmacol Sin 17:481–484 48. Frobert Y, Creminon C, Cousin X, Remy MH, Chatel JM, Bon S, Bon C, Grassi J (1997) Biochim Biophys Acta 1339:253– 267 49. Camps P, Cusack B, Mallender WD, El Achab R, Morral J, Munoz-Torrero D, Rosenberry TL (2000) Mol Pharmacol 57:409–417 397